Concourse Financial Group Securities’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1
Closed -$92 2247
2024
Q3
$96 Sell
1
-6
-86% -$585 ﹤0.01% 2202
2024
Q2
$642 Buy
+7
New +$650 ﹤0.01% 2177
2023
Q3
Sell
-165
Closed -$15.2K 2310
2023
Q2
$15.1K Sell
165
-16
-9% -$1.31K ﹤0.01% 1537
2023
Q1
$13.3K Sell
181
-210
-54% -$18.2K ﹤0.01% 1587
2022
Q4
$32.7K Buy
+391
New +$35.3K ﹤0.01% 1265
2022
Q3
Sell
-410
Closed -$48.9K 2032
2022
Q2
$43K Sell
410
-43
-9% -$5.49K ﹤0.01% 1153
2022
Q1
$78K Sell
453
-402
-47% -$60.1K 0.01% 964
2021
Q4
$138K Buy
855
+376
+78% +$60.4K 0.01% 865
2021
Q3
$71K Buy
479
+23
+5% +$4.78K ﹤0.01% 1155
2021
Q2
$112K Buy
456
+22
+5% +$5.77K 0.01% 934
2021
Q1
$115K Buy
434
+96
+28% +$27.1K 0.01% 875
2020
Q4
$99K Buy
338
+44
+15% +$11.3K 0.01% 892
2020
Q3
$70K Buy
294
+107
+57% +$24.3K 0.01% 914
2020
Q2
$37K Buy
187
+16
+9% +$2.98K ﹤0.01% 1080
2020
Q1
$31K Buy
+171
New +$30.4K ﹤0.01% 1072
2019
Q2
Sell
-12
Closed -$1.42K 2217
2019
Q1
$1K Buy
+12
New +$1.51K ﹤0.01% 2118

Other funds holding AMED

Concourse Financial Group Securities's AMED Position: Q4 2024 in Review

Concourse Financial Group Securities sold out of Amedisys (AMED) in Q4 2024, closing a stake of 1 share — an estimated $92 sold.

Concourse Financial Group Securities first reported a position in AMED in Q1 2019 and held it in 16 quarters. The position peaked at $138K in Q4 2021. 291 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

  • Concourse Financial Group Securities reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
  • Concourse Financial Group Securities sold 1 Amedisys share in Q4 2024, an estimated $92.
  • Concourse Financial Group Securities first reported a position in Amedisys in Q1 2019 and held it in 16 quarters.
  • Concourse Financial Group Securities's Amedisys position peaked at $138K in Q4 2021.
  • 291 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Concourse Financial Group Securities's 13F filing for Q4 2024, filed 13 Feb 2025.